Ku86 has been shown to be involved in DNA double-strand break (DSB) repair and radiosensitivity in rodents, but its role in human cells is still under investigation. The purpose of this study was to evaluate the radiosensitivity and DSB repair after transfection of a Ku86-antisense in a human fibroblast cell line. Simian virus 40-transformed MRC5V1 human fibroblasts were transfected with a vector (pcDNA3) containing a Ku86-antisense cDNA. The main endpoints were Ku86 protein level, Ku DNA end-binding and DNA protein kinase activity, clonogenic survival, and DSB repair kinetics. After transfection of the Ku86-antisense, decreased Ku86 protein expression, Ku DNA end-binding activity, and DNA protein kinase activity were observed in the uncloned cellular population. The fibroblasts transfected with the Ku86-antisense showed also a radiosensitive phenotype, with a surviving fraction at 2 Gy of 0.29 compared with 0.75 for the control and 20% of unrepaired DSB observed at 24 hours after irradiation compared with 0% for the control. Several clones were also isolated with a decreased level of Ku86 protein, a surviving fraction at 2 Gy between 0.05 and 0.40, and 10 -20% of unrepaired DSB at 24 hours. This study is the first to show the implication of Ku86 in DSB repair and in the radiosensitivity of human cells. This investigation strongly suggests that Ku86 could constitute an appealing target for combining gene therapy and radiation therapy. Cancer Gene Therapy (2000) 7, 339 -346
R epair of DNA double-strand breaks (DSB) has been shown to play a key role in the radiosensitivity of mammalian cells, because a parallel between cell killing and the yield of unrepaired DSB has been found in many cellular models. [1] [2] [3] [4] [5] [6] [7] [8] Several genes involved in the DSB repair process have been identified recently in yeast (rad51-57) 9 -13 and in rodents (XRCC1-8). 14 -18 Among them, XRCC5 and XRCC6 encode for two subunits of the heterodimer Ku (Ku86 and Ku70, respectively). 19 -21 Ku was originally identified as an autoantigen recognized by sera of patients with autoimmune disorders. 22 Biochemical analyses of Ku demonstrated that it bound in vitro to DNA termini in the DNA structure without apparent sequence specificity. [23] [24] [25] Ku has also been shown to possess DNA-dependent adenosine triphosphatase 26 and helicase 27 activities. In vitro, heterodimerization of active Ku requires the cotranslation of both subunits. 28 Ku is the DNA-targeting component of a larger complex, the DNA-dependent protein kinase (DNA-PK), which is a serine-threonine PK that requires DSB for activity. 18, 29 The catalytic subunit of the DNA-PK complex (XRCC7/DNA-PKcs) is a 460-kDa protein that belongs to the phosphatidylinositol 3-kinase (p110) family. 30 DNA-PKcs is recruited to DNA by Ku binding 18 and can phosphorylate several transcription factors in vitro, including p53, c-Jun, and other DNA-binding proteins. 31, 32 In rodents, Ku DNA binding represents the predominant, if only, mechanism for DNA-PK activation, because the Ku-defective mutants have undetectable DNA-PK activity. 33 Also in rodents, the DNA-PK complex has been shown to play an important role in the response to ionizing radiation, because mutations in one of the DNA-PK subunits lead to an extreme x-ray-sensitivity along with a deficiency in both DSB repair and V(D)J recombination, 34, 35 suggesting that the integrity of this complex is necessary for a normal enzymatic activity. It was also possible to complement the deficient phenotype of DNA-PK mutant rodent cell lines by transferring the corresponding genes for Ku86 and DNA-PKcs. [35] [36] [37] The role of DNA-PK complex in the radiosensitivity of human cells is still being investigated. Interestingly, DNA-PKcs presents a sequence homology in the carboxyl-terminal domain with the ataxia telangiectasia gene (ATM) corresponding to the phosphatidylinositol 3-kinase superfamily catalytic domain. 30 In contrast to the rodent situation, no syndrome related to DNA-PK has been identified in humans. So far, only one mutant human cell line that is deficient in the DNA-PK complex has been reported. This cell line (MO59J) is derived from a human malignant glioma and has been found to lack expression of DNA-PKcs and to be x-ray hypersensitive and deficient in DSB repair. 4, 38 However, it is not clear whether the extreme radiosensitivity of this cell line is due only to the mutation in DNA-PKcs or to alterations in other genes involved in determining the cellular radiosensitivity. Indeed, the ATM protein level was recently found to be very low in this model. 39 With regard to Ku proteins, which are the second component of the DNA-PK complex, no mutant cell line of human origin has been found defective, and the role of the Ku protein in the radiosensitivity of human cells has not been established. In addition, the situation in human cells may be different from rodents; it has been reported recently that a second gene known as Ku86 autoantigen-related protein-1 (KARP-1), which is expressed specifically in primates from the Ku86 locus, is implicated in the control of DNA-PK activity, because the dominant negative expression of KARP-1 results in x-ray sensitivity. 40 Thus, it has been suggested that KARP-1 may be capable of interacting with DNA-PKcs in human cells. 40 The purpose of this study was to investigate the role of Ku86 in the response of human cells to ionizing radiation. We report here the characterization of humantransformed fibroblasts after transfection of an antisense cDNA sequence to Ku86. IN addition, we have assessed the function of the DNA complex, the intrinsic radiosensitivity, and DSB repair kinetics.
MATERIALS AND METHODS

Plasmid construction
The 3.5-kb cDNA encoding the human Ku86 subunit that was previously cloned from the HGT1 cells 41 was ligated in the antisense orientation between the EcoRI sites of a pcDNA3.1 eukaryotic vector (Invitrogen, Groningen, The Netherlands). This vector contained the human cytomegalovirus promoter and the neomycin gene for selection of geneticin G418-resistant clones. The orientation of the insert into the vector was confirmed by sequencing according to the dideoxynucleotide chain-termination method of Sanger, using a Sequenase kit (version 2.0, USB, Amersham, Little Chalfont, UK).
Cell lines
MRC5V1 is a simian virus 40-transformed human fibroblast cell line obtained from the viral infection of its nontransformed counterpart MRC5. 42, 43 This cell line was selected for its pronounced radioresistance (surviving fraction at 2 Gy (SF2) ϭ 0.75).
All of the cell lines were routinely cultured in Nunclon plastic flasks (Nunc, Roskilde, Denmark) containing Earle's minimum essential medium supplemented with 20% fetal calf sera and antibiotics.
Transfection
Transfections of the MRC5V1 cells by the plasmid constructs were achieved by a standard CaPO 4 precipitation method. MRC5V1 cells were transfected with pcDNA3 containing the Ku86-antisense (MRC5V1-anti-Ku86) and with pcDNA3 null as a control (MRC5V1-T). Selection of geneticin-resistant colonies was obtained by adding 0.5-1 mg/mL Ϫ1 geneticin G418 (Sigma, St. Louis, Mo) to the medium.
Western blotting
A total of 50 g of whole-cell extracts were boiled in sodium dodecyl sulfate-polyacrylamide gel electrophoresis loading buffer and separated by 9% sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The protein transfer to nitrocellulose was performed with a Western blotting system and blocked for 2 hours in 5% milk solution. Thereafter, Ku86 primary monoclonal antibody (30F3) was diluted 1/200 overnight in 5% milk solution. 41 After washing for 1 hour, the secondary anti-mouse antibody diluted at 1/5000 was applied to the membrane in 5% milk solution and subsequently rewashed. Blotting was revealed using an enhanced chemiluminescence kit (Amersham, Little Chalfont, UK).
Cell extracts
For separate analysis of cytoplasmic and nuclear fractions, the extracts were prepared as follows: Approximately 5 ϫ 10 7 exponentially growing cells were scraped from the dishes in phosphate-buffered saline using a rubber policeman and centrifuged at 4°C for 5 minutes at 1500 rpm. Cell pellets were resuspended in 4 per volume of cells (PVC) of ice-cold hypotonic buffer 1 (10 mM tris(hydroxymethyl)aminomethane (pH 7.5), 10 mM MgCl 2 ) in the presence of proteinase inhibitors (0.5 mM phenylmethylsulfonyl fluoride, 0.5 g/mL apoprotin, 0.5 g/mL chymostatin, 0.5 g/mL leupeptin, and 1.5 g/mL pepstatin) and incubated on ice for 15 minutes. The swollen cells were disrupted by 10 strokes of Dounce B homogenizer, and the suspension was centrifuged at 4°C for 2 minutes at 5000 rpm. The cytoplasmic supernatant was carefully removed from the nuclear pellet. Nuclear pellets were resuspended in buffer I plus 350 mM NaCl and incubated on ice for 30 minutes. The suspensions were sedimented by a 30-minute centrifugation at 4°C, and the supernatant was removed (nuclear fraction). Ammonium persulfate (450 mM) was added to both cytoplasmic and nuclear fractions; after centrifugation, the protein pellets were resuspended in dialysis buffer and dialyzed as described previously. 44 
Band shift assay
In human cell lines, Ku represents the major double-stranded DNA (dsDNA)-end-binding protein, and its activity can be easily detected using dsDNA fragments in an electrophoretic mobility shift assay (EMSA). It has been demonstrated that a 25-to 30-bp dsDNA fragment is the minimum length required for the binding of a single Ku heterodimer. 23 The 25-mer dsDNA was prepared as described previously. 45 For band shift assay, 0.1 ng of 32 P-labeled DNA (100,000 cpm) was incubated with 2.5 g of cell extracts and 1 g of closed circular plasmid DNA as a nonspecific competitor in 20 L of binding buffer (10 mM tris(hydroxymethyl)aminomethaneHCl (pH 8.0), 1 mM ethylenediaminetetraacetic acid, 10% glycerol, and 50 mM KCl) at room temperature for 10 minutes. The samples were electrophoresed on a 4% polyacrylamide gel at 4°C for 2 hours at 100 V. The gel was dried on Whatman paper and exposed to x-ray film. Excised bands that corresponded either to free probe or to DNA end-binding complexes were quantified by scintillation counting. The Ku DNA end-binding activity was expressed as the percentage of radioactivity that corresponded to the DNA-protein complexes (cpm in DNA-protein complexes/[cpm in DNA-complexes ϩ cpm in free probe] ϫ 100).
DNA-PK assay
The DNA-PK "pulldown" kinase assay was performed as described previously 33 with slight modifications. 44 Each sample was assayed in the presence of either DNA-PK-specific peptide substrate (SQE peptide: EPPLSQEAFADLLKK) or a negative control peptide (SEQ peptide: EPPLSEQAFADLLKK). DNA-PK activity was expressed in cpm incorporated in the SQE peptide or in the SEQ peptide for a given extract.
Irradiation and clonogenic survival assay
Irradiation was performed using a 137 Cs ␥-ray source at a dose rate of 1.45 Gy/min Ϫ1 as described previously. 1 Briefly, survival curves were obtained by harvesting cells in exponential phase and irradiating 4 hours later. The linear-quadratic model was used for fitting survival curves. 46 Quantification of radiosensitivity was obtained using the SF2 and by calculating the mean inactivation dose (D ), which is used to quantify radiosensitivity in a dose-independent manner. 46 
Kinetics of DSB repair
Cells were prepared for DSB repair assay as reported previously, 3 with the notable exception that cells were irradiated in the exponential phase of growth. Briefly, cells were irradiated at 4°C (30 Gy) with a 137 Cs ␥-ray source as described above. DSB repair was allowed for up to 24 hours by incubating cells at 37°C immediately after irradiation. Thereafter, cells were trypsinized on ice and agarose plugs of cells containing 2 ϫ 10 6 cells/mL Ϫ1 were prepared. The cells embedded in the plugs were lysed with sarcosine at 50°C for 38 hours. Migration of DNA fragments was performed at 14°C with pulsed field gel electrophoresis (Chef DRIII, Bio-Rad, Hercules, Calif) in a megabase-sized region. DSB data were expressed in terms of fraction of activity released (FAR), as reported previously. 3 The repair kinetics data were presented as the percentage of FAR remaining and were fitted to the variable repair half-time model as described previously. 47 
Micronuclei assay
The cytokinesis block technique was used to assess the micronuclei yields. This method has been described previously; 48 it provides an estimate of radiation-induced chromosomal damage. Briefly, 3 g/mL Ϫ1 of cytochalasin B (Sigma) was added to cell cultures after ␥-ray irradiation (6 Gy). Cells were incubated for up to 72 hours, fixed in methanol-acetic acid (3:1), and stained in 10% Giemsa (Sigma). Micronuclei were scored by optical microscopy. Data were obtained by counting 100 cells.
RESULTS
Analysis of protein levels by Western blot
The expression of the Ku86 protein was measured by Western blotting using a monoclonal antibody crossreacting with this protein. Figure 1 shows that uncloned MRC5V1-anti-Ku86 cells as well as the two hypersensitive clones 1 and 8 (Fig 1) exhibited a decreased level of Ku86 protein compared with control cells (MRC5V1-T). In contrast, the level of expression of Ku70 and actin proteins was not modified (data not shown).
Activity of the two subunits of DNA-PK complex
We subsequently investigated the activity of the two subunits of the DNA-PK complex (i.e., Ku DNA end-binding activity and kinase activity of the whole complex) in the uncloned antisense-transfected cells, MRC5V1-anti-Ku86, which exhibited a stable radiosensitive phenotype. As described previously, 45 we used a 25-mer ds probe for analysis by EMSA. As shown on Figure 2A , a unique DNA-protein complex that correspond to Ku DNA end binding activity (complex C) was detected. The DNA-PK activity was decreased by 2-fold in the nuclear extracts obtained from MRC5V1-anti-Ku86 compared with the control (Fig 2B) .
Clonogenic survival assay
The radiosensitivities of MRC5V1 cells transfected with pcDNA3 null (MRC5V1-T) and MRC5V1 cells transfected with Ku86-antisense (MRC5V1-anti-Ku86) were compared (Fig 3) . The SF2 were 75% for MRC5V1-T and 29% for MRC5V1-anti-Ku86; the mean inactivation The radiosensitivities of several subclones were also measured, giving SF2 ranging from 5% to 40% (data not shown). We isolated two clones (clones 1 and 8) that showed a dramatic increase in radiosensitivity: clone 1 had a SF2 of 9% (D ϭ 1 Gy) and clone 8 had a SF2 of 5% (D ϭ 0.8 Gy) (Fig 4) . However, the strong radiosensitivity of these two clones was clearly evident only during the first few culture passages after the cloning, in contrast to the uncloned population, which showed a stable radiosensitivity for Ͼ20 passages (data not shown).
DSB repair kinetics
The kinetics of DSB repair were studied by measuring the percent of FAR remaining as a function of the time, after an exposure of 30 Gy. After the irradiation, the percent of FAR remaining dropped rapidly for up to 6 hours for the MRC5V1-T-cell line, which showed no residual FAR after 24 hours. By contrast, the DSB repair curve of the MRC5V1-anti-Ku86 cell line exhibited a residual FAR of 20% at 24 hours (Fig 5) . The hypersensitive clones 1 and 8 also showed a marked decrease in DSB repair: at 24 hours, the percentage of FAR remaining was 16 and 24, respectively; unfortunately, it was not possible to assess the complete DSB repair kinetics for these clones because of their instability.
Micronuclei assay
The yield of radiation-induced micronuclei was scored up to 72 hours following 6 Gy. The MRC5V1-T reached a steady state after 24 hours for repair, whereas the yield of micronuclei increased with repair time for the MRC5V1-anti-Ku86 cell line; the maximum was seen at 48 hours. Whatever the repair time, the yield of micronuclei was always higher in MRC5V1-anti-Ku86 cells compared with in controls (Fig 6) .
DISCUSSION
The aim of the present study was to inhibit the expression of one of the Ku subunits and to investigate its consequences on DNA repair and radiosensitivity. For this purpose, radioresistant, transformed MRC5V1 fibroblasts have been transfected with Ku86-antisense.
The Ku protein is the DNA-binding component of the human DNA-PK complex and is present at high constitutive levels in human cells. 29, 34 However, its role in DSB repair and radiosensitivity is still unknown in humans. Indeed, no human syndrome and no mutant cells lines deficient for Ku protein have been reported, in contrast to the situation in rodents, in which several syndromes have been reported as well as several cell lines mutated for Ku86 or Ku70. 34 The extreme radiosensitivity and DSB repair deficiency found in these mutated rodent cell lines, as well as in the Ku86 49 or Ku70 50 knockout mice, 49 justify the hypothesis that a comparable mechanism could be involved in human cells. In addition, a recent study suggests that in human cells Ku might also represent the major DNA-binding component of DNAPKcs, because human peripheral B lymphocytes expressing a truncated form of Ku86 (Ku69) were unable to recruit the DNA-PKcs and were deficient in the enzymatic activity of the DNA-complex. 44 Our results showed a pronounced decrease in the basal level of Ku86 protein after transfection of the Ku86-antisense (Fig 1) .
The decrease in Ku86 protein expression appeared to be correlated with the decrease in Ku DNA end-binding activity (Fig 2A) . Interestingly, the decrease in the level of Ku86 expression was not associated with a concomitant decrease in Ku70 expression. These data are in contrast to previous reports in rodents showing that the individual Ku subunits were degraded when not dimerized, because the Ku70 protein was undetectable in Ku86 rodent mutants. 50 In our study, the decrease in Ku DNA end-binding activity is potentially due to the reduction of the amount of Ku86 protein to substoechiometric levels with Ku70, because both subunits are equally necessary to form stable complexes in an EMSA. 28 The decrease in Ku DNA end-binding activity alone may contribute to the observed radiosensitivity and DSB repair defect. Indeed, recent studies suggest that Ku, independently of the DNA-PKcs, has a direct role in the repair of DSB by stimulating the DNA end-joining by mammalian ligases. 51, 52 However, we demonstrate here that the decrease in Ku DNA endbinding activity resulted in a concomitant decrease in the kinase activity of the DNA-PK complex contributed to the DSB repair defect (Fig 2B) . In both cell lines, the kinase activity of DNA-PK was undetectable in cytoplasmic extracts; this finding is compatible with previous work indicating that the expression of the catalytic subunit DNA-PKcs was restricted to the nucleus (Ref. 18 and data not shown).
These results also suggest that Ku is a major activating component of DNA-PK in human cells, whereas the DNA binding and activation of DNA-PKcs in the absence of Ku 53, 54 are known to represent minor pathways of DNA-PK activation. Our results suggest that, at least in this model, the level of free Ku represents a limiting factor for DNA-PK activation. Correlated with a permanent reduction in Ku86 protein level, the uncloned transfected cellular population exhibited a stable radiosensitive phenotype for Ͼ20 passages (Fig 3) . In contrast, the Ku86-antisense function was lost after several culture passages in the two most radiosensitive clones, clones 1 and 8 (Fig 4) ; these clones exhibited a restored radioresistance phenotype and a normal Ku86 expression (data not shown). This lack of stability after several months has also been reported in human fibroblasts transfected by an ATMantisense, which conferred to the cells a highly radiosensitive phenotype. 55 The observed radiosensitivity of the transfected cells was correlated with a repair deficiency (20% of unrepaired DSB at 24 hours for repair), providing strong evidence for the role of Ku86 in DSB repair in human cells.
The defect in DSB repair in the Ku86-antisensetransfected cells was also reflected by the number of micronuclei per cell, which was significantly higher for the MRC5V1-anti-Ku86. The correlation between radiation-induced micronuclei and cell killing has long been known. 56 It was also established that micronuclei arise from acentric and centric chromosome fragments, 57 and that micronuclei result from DSB that have not been repaired, providing an indirect measure of DSB repair defect. 48, 58 In conclusion, our data represent the first evidence of cellular radiosensitization due to transfer of human Ku86-antisense RNA and demonstrate that interference with Ku86 gene expression can result in a radiosensitive phenotype in human cells. This strongly suggests that Ku86 may be an appealing target for combined gene therapy and radiation therapy. In that aim, further experiments are in progress to evaluate the possibility of radiosensitizing human cancer cells, using a comparable approach.
